chloroquine diphosphate has been researched along with Heart Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Beck-Friis, J; Gisslen, M; Leach, S; Omerovic, E; Yilmaz, A; Zeijlon, R | 1 |
1 other study(ies) available for chloroquine diphosphate and Heart Failure
Article | Year |
---|---|
No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
Topics: Aged; Antiviral Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Chloroquine; COVID-19; COVID-19 Drug Treatment; Creatinine; Electrocardiography; Female; Heart Failure; Heart Injuries; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Troponin T | 2021 |